$ACRS Aclaris Therapeutics, Inc. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Aclaris Therapeutics, Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in Aclaris Therapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Aclaris Therapeutics, Inc. for free.

CIK Number: 0001557746
IRS Number: 460571712
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: ACRS
Company Address: 640 LEE ROAD SUITE 200 WAYNE 19087
Phone number: 484-324-7933

Aclaris Therapeutics, Inc. operates as a dermatologist-led biopharmaceutical company, which engages in identifying, developing, and commercializing novel drugs to address the needs in medical and aesthetic dermatology and immunology. It operates through Therapeutics and Contract Research segments. The Therapeutics segment focuses in identifying, developing, and commercializing different therapies to address significant unmet needs in medical and aesthetic dermatology. The Contract Research segment provides laboratory services under contract research arrangements to pharmaceutical and biotech companies. The company was founded by Neal S. Walker, Frank Ruffo, Kamil Ali-Jackson, Christopher V. Powala, and Stuart D. Shanler in July 2012 and is headquartered in Wayne, PA.

Market Capitalization: $537.94M
Prev close: $25.25
Average Daily Volume: 309,565
Days Low: $24.86
Year Low: $14.12
Year High: $31.80

Aclaris Therapeutics, Inc. Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
Ali-Jackson KamilChief Legal Officer158,6184,005,105shares bought: 241,554 / shares sold: -120,723 STRONG BUYMay 07 20213 days ago
Gordon David N.Chief Medical Officer108,1352,730,409shares bought: 390,897 / shares sold: -107,128 STRONG BUYMar 03 20212 months ago
Ruffo FrankChief Financial Officer209,0595,278,740shares bought: 143,806 / shares sold: -386,830 STRONG SELLApr 26 202114 days ago
Walker NealPresident and CEO1,192,42730,108,782shares bought: 666,205 / shares sold: -237,259 STRONG BUYApr 26 202114 days ago

View all Aclaris Therapeutics, Inc. insiders.

Aclaris Therapeutics, Inc. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
May 07 2021ACRSAclaris Therapeuti ...Ali-Jackson KamilChief Legal OfficerOption ExerciseM10.665,41657,7350
May 07 2021ACRSAclaris Therapeuti ...Ali-Jackson KamilChief Legal OfficerOption ExerciseM10.6615,000159,9005,416
May 07 2021ACRSAclaris Therapeuti ...Ali-Jackson KamilChief Legal OfficerSellS23.992,10050,376143,618145.7 K to 143.6 K (-1.44 %)
May 07 2021ACRSAclaris Therapeuti ...Ali-Jackson KamilChief Legal OfficerSellS23.233,31677,016145,718149 K to 145.7 K (-2.22 %)
May 07 2021ACRSAclaris Therapeuti ...Ali-Jackson KamilChief Legal OfficerBuyM10.665,41657,735149,034143.6 K to 149 K (+3.77 %)
May 07 2021ACRSAclaris Therapeuti ...Ali-Jackson KamilChief Legal OfficerSellS23.863,10274,016143,618146.7 K to 143.6 K (-2.11 %)
May 07 2021ACRSAclaris Therapeuti ...Ali-Jackson KamilChief Legal OfficerSellS23.3211,898277,438146,720158.6 K to 146.7 K (-7.50 %)
May 07 2021ACRSAclaris Therapeuti ...Ali-Jackson KamilChief Legal OfficerBuyM10.6615,000159,900158,618143.6 K to 158.6 K (+10.44 %)
May 05 2021ACRSAclaris Therapeuti ...Ali-Jackson KamilChief Legal OfficerOption ExerciseM10.6615,000159,90020,416
May 05 2021ACRSAclaris Therapeuti ...Ali-Jackson KamilChief Legal OfficerOption ExerciseM10.6615,000159,90035,416
May 05 2021ACRSAclaris Therapeuti ...Ali-Jackson KamilChief Legal OfficerOption ExerciseM10.6615,000159,90050,416
May 05 2021ACRSAclaris Therapeuti ...Ali-Jackson KamilChief Legal OfficerSellS24.3649812,129143,618144.1 K to 143.6 K (-0.35 %)
May 05 2021ACRSAclaris Therapeuti ...Ali-Jackson KamilChief Legal OfficerSellS23.9714,502347,584144,116158.6 K to 144.1 K (-9.14 %)
May 05 2021ACRSAclaris Therapeuti ...Ali-Jackson KamilChief Legal OfficerBuyM10.6615,000159,900158,618143.6 K to 158.6 K (+10.44 %)
May 05 2021ACRSAclaris Therapeuti ...Ali-Jackson KamilChief Legal OfficerSellS24.471,27931,296143,618144.9 K to 143.6 K (-0.88 %)

View all Aclaris Therapeutics, Inc. insider transactions.